Malaria Vaccine Prevents 1 in 8 Child Deaths in Africa

A proven malaria vaccine is finally turning the tide against one of Africa's deadliest childhood diseases, preventing one in eight deaths among young children in areas where it's been introduced.

The World Health Organization announced Friday that a four-year study across Ghana, Kenya, and Malawi confirms the RTS,S vaccine is saving lives in real-world conditions. The findings, published in The Lancet medical journal, represent the first large-scale proof that malaria vaccination works outside controlled trials.

The numbers tell a powerful story. In 2024 alone, malaria killed an estimated 438,000 African children under age five. Health officials say expanding access to this vaccine and a newer version called R21 could save tens of thousands of young lives annually.

Dr. Kate O'Brien, WHO Director for Immunization, Vaccines and Biologicals, called the evidence "very solid" proof that malaria vaccines can change the trajectory of child deaths in Africa. She's urging immediate investment to get shots to more children at risk.

The vaccine works best alongside other prevention measures like insecticide-treated bed nets, testing, and quick treatment when infections occur. Dr. Daniel Ngamije Madandi, who leads WHO's malaria department, says vaccination strengthens the overall response and helps more families access prevention tools.

The Ripple Effect

The vaccine rollout is creating unexpected benefits beyond malaria protection. The four-dose schedule brings children back to health clinics multiple times, creating natural opportunities to deliver other childhood vaccines, vitamin A supplements, and mosquito nets to families who need them.

Countries now introducing the vaccines are expected to see similar or even better results than the initial three nations. More African countries are beginning their own rollout programs, building on the proven success.

The main challenge isn't supply or demand. Both vaccines are available in sufficient quantities, and countries are eager to protect their children. The barrier is funding for both purchasing vaccines and delivering them alongside other essential malaria prevention tools.

WHO is calling on international partners to provide sustained support so the momentum continues and reaches the most vulnerable communities. Every delay means more preventable deaths among children who could be protected.

This breakthrough represents decades of scientific work finally paying off in saved lives across an entire continent.